Can LMWH improve the outcome of patients with inoperable stage III non-small cell lung cancer?

AIM OF THE STUDY: Lung cancer is the most common malignancy, accounting for one-third of all deaths from cancer. Some studies have shown that low molecular weight heparin (LMWH) significantly prolongs the survival of patients with non-small cell lung cancer (NSCLC). The aim of this study was to dete...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kucukoner, Mehmet, Isikdogan, Abdurrahman, Kaplan, Muhammed Ali, Inal, Ali, Zinciroglu, S., Cit, Murtaza, Cil, Timucin, Karadayi, Bilgehan, Dirier, Ahmet, Yildiz, Ismail
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Termedia Publishing House 2012
Gaiak:
Original Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3687451/
https://ncbi.nlm.nih.gov/pubmed/23788920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2012.31771
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak